Total Funding
43
Total FundingSeries B raised
Growth Score
pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
71490
TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues.
Michael Cima: DirectorPast Role: Springleaf Therapeutics, Founder- Christopher J. Searcy: Chief Medical OfficerPast Role: TARIS Biomedical, Senior VP Corporate Development and Chief Business Officer
About the Company
TARIS Biomedical develops new therapies designed for the treatment of difficult-to-treat bladder diseases. The company's system is designed to continuously release drugs in the bladder over weeks to months and is deployed and retrieved using minimally-invasive, in-office procedures, enabling drug release to be tailored to match the needs of
each disease.
